The is an equity fund that invests in international equities of companies active in the fields of biotechnology, pharmaceuticals, telecommunications, technology and computer technology and which are traded on the major stock markets of the continents of America, Europe, Asia and Australia. In addition, however, the sub-fund assets can also be invested in stock corporations that are domiciled in emerging countries. The Sub-Fund invests at least 51% of its value directly in equity investments on an ongoing basis.